Intact Therapeutics Alternatives & Competitors

12 companies similar to Intact Therapeutics — Smart gels for local drug delivery to the gastrointestinal tract

Visterra Inc.

We bring better biologics to life. Biospace Best Place to Work 2024!

139 Series C $125.39M

Waltham, United States

Biotechnology Health Care +1

Re-Vana Therapeutics

To advance the quality of care for patients suffering from sight-threatening diseases.

24 Series A $14.45M

United Kingdom

Health Care Health and Wellness +1

TARIS

Innovative therapies for challenging bladder conditions, with a tailored, extended-release...

4 Series B $113.09M

Biotechnology Health Care +2

TransCode Therapeutics, Inc.

Delivering a cancer-free future

11 Post-IPO Equity $28.05M

Newton, United States

Biotechnology Health Care +1

Track all Intact Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Cerebral Therapeutics, Inc.

A clinical stage pharmaceutical company developing innovative treatments for neurological...

22 Series C $85.80M

Aurora, United States

Biotechnology Health Care +2

i2o Therapeutics

Boston-based biotech startup developing novel biologic therapies

13 Series A

Cambridge, United States

Biotechnology Health Care +1

Capstan Therapeutics

Advancing cell engineering to develop therapeutics for a broad range of diseases

14 Acquired $2.44B

Biotechnology Health Care +1

Chimeron Bio

Redefining genetic medicine with future-forward RNA technology designed to deliver meaning...

12 Angel $1.15M

Philadelphia, United Stat...

Biotechnology Health Care +1

Mural Oncology

Leveraging our protein engineering platform to improve cytokine-based immunotherapies for...

112 Corporate Round $275.00M

Waltham, United States

Health Care Health and Wellness

Tubulis GmbH

Reimagining ADCs.

73 Acquired $3.66B

Germany

Biotechnology Health Care +3

Pinteon Therapeutics

Pioneering therapies targeting Pin1 to normalize disease processes and enhance patient out...

2-10 Series B $51.60M

Biotechnology Health Care +1

Cellestia Biotech

Cellestia develops targeted therapies for cancer patients with no other options, including...

15 Non Equity Assistance $48.17M

Basel, Switzerland

Biopharma Biotechnology +2

About Intact Therapeutics

Intact Therapeutics is a US-based startup founded in 2015, focusing on developing smart gels for localized drug delivery to the gastrointestinal tract. With a mission to address unmet needs in the digestive tract, the company operates in the industries of Health Care, Health and Wellness, and Logistics and Delivery. Th...

Taxonomy

Drug Delivery, Gastrointestinal Tract, Targeted Therapies, Local Drug Delivery, Digestive Tract, Smart Gels, Biomedical Engineering, Pharmaceuticals, Innovative Therapies

Frequently Asked Questions

Companies similar to Intact Therapeutics include Visterra Inc., Re-Vana Therapeutics, TARIS, TransCode Therapeutics, Inc., Cerebral Therapeutics, Inc.. They work in Health Care and Health and Wellness and share Intact Therapeutics's focus on targeted therapies, innovative therapies and drug delivery.

Bounce Watch lists 12 companies that share Intact Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Intact Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Intact Therapeutics Profile Visterra Inc. Alternatives Re-Vana Therapeutics Alternatives TARIS Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Intact Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 17 Jun 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.